{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:29:50Z","timestamp":1779308990415,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00428-024-03813-9","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T07:01:49Z","timestamp":1715410909000},"page":"323-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of CD5\/SOX11 double-negative pleomorphic mantle cell lymphoma"],"prefix":"10.1007","volume":"485","author":[{"given":"Wen-Yu","family":"Chuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee-Yung","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ju","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shir-Hwa","family":"Ueng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Wen","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Tsung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ling","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Po","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Liang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jau-Song","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuen","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-525X","authenticated-orcid":false,"given":"Shih-Sung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"3813_CR1","first-page":"285","volume-title":"WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Seto M et al (2017) Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised, 4th edn. IARC, Lyon, pp 285\u2013290","edition":"4"},{"key":"3813_CR2","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1182\/blood-2017-08-737502","volume":"132","author":"M Dreyling","year":"2018","unstructured":"Dreyling M, Klapper W, Rule S (2018) Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge! Blood 132:2722\u20132729","journal-title":"Blood"},{"key":"3813_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/PAS.0000000000001278","volume":"43","author":"Y Miao","year":"2019","unstructured":"Miao Y, Lin P, Saksena A et al (2019) CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients. Am J Surg Pathol 43:1052\u20131060","journal-title":"Am J Surg Pathol"},{"key":"3813_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/PAS.0b013e318241f050","volume":"36","author":"W Zeng","year":"2012","unstructured":"Zeng W, Fu K, Quintanilla-Fend L et al (2012) Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol 36:214\u2013219","journal-title":"Am J Surg Pathol"},{"key":"3813_CR5","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/his.13161","volume":"70","author":"WY Chuang","year":"2017","unstructured":"Chuang WY, Chang H, Chang GJ et al (2017) Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall. Histopathology 70:986\u2013999","journal-title":"Histopathology"},{"key":"3813_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/PAS.0000000000001233","volume":"43","author":"J Xu","year":"2019","unstructured":"Xu J, Wang L, Li J et al (2019) SOX11-negative mantle cell lymphoma: clinicopathologic and prognostic features of 75 patients. Am J Surg Pathol 43:710\u2013716","journal-title":"Am J Surg Pathol"},{"key":"3813_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/PAS.0000000000001390","volume":"44","author":"WY Chuang","year":"2020","unstructured":"Chuang WY, Chang ST, Yuan CT et al (2020) Identification of CD5\/cyclin D1 double-negative pleomorphic mantle cell lymphoma: a clinicopathologic, genetic, and gene expression study. Am J Surg Pathol 44:232\u2013240","journal-title":"Am J Surg Pathol"},{"key":"3813_CR8","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/cncr.28664","volume":"120","author":"CY Ok","year":"2014","unstructured":"Ok CY, Xu-Monette ZY, Tzankov A et al (2014) Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer 120:1818\u20131829","journal-title":"Cancer"},{"key":"3813_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","volume":"61","author":"SC Hsiao","year":"2012","unstructured":"Hsiao SC, Cortada IR, Colomo L et al (2012) SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma. Histopathology 61:685\u2013693","journal-title":"Histopathology"},{"key":"3813_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/PAS.0000000000000120","volume":"38","author":"D Juskevicius","year":"2014","unstructured":"Juskevicius D, Ruiz C, Dirnhofer S et al (2014) Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements. Am J Surg Pathol 38:719\u2013727","journal-title":"Am J Surg Pathol"},{"key":"3813_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1309\/AJCPUIDW2CPTA1JA","volume":"143","author":"M Al-Kawaaz","year":"2015","unstructured":"Al-Kawaaz M, Mathew S, Liu Y et al (2015) Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. Am J Clin Pathol 143:288\u2013299","journal-title":"Am J Clin Pathol"},{"key":"3813_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40364-019-0162-2","volume":"7","author":"D Gao","year":"2019","unstructured":"Gao D, Liu Z (2019) Cyclin D1 + large B-cell lymphoma with altered CCND1 and BCL-6 rearrangements: a diagnostic challenge. Biomark Res 7:11","journal-title":"Biomark Res"},{"key":"3813_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/hon.2779","volume":"38","author":"AM Parrott","year":"2020","unstructured":"Parrott AM, Haggiagi AM, Murty VV et al (2020) Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma? Hematol Oncol 38:817\u2013822","journal-title":"Hematol Oncol"},{"key":"3813_CR14","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1097\/HS9.0000000000000505","volume":"5","author":"J Cheng","year":"2021","unstructured":"Cheng J, Hashem MA, Barab\u00e9 F et al (2021) CCND1 genomic rearrangement as a secondary event in high grade B-cell lymphoma. Hemasphere 5:e505","journal-title":"Hemasphere"},{"key":"3813_CR15","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"3813_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275\u2013282","journal-title":"Blood"},{"key":"3813_CR17","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","volume":"30","author":"NA Johnson","year":"2012","unstructured":"Johnson NA, Slack GW, Savage KJ et al (2012) Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30:3452\u20133459","journal-title":"J Clin Oncol"},{"key":"3813_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00428-015-1845-1","volume":"467","author":"WY Chuang","year":"2015","unstructured":"Chuang WY, Chang H, Shih LY et al (2015) CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma. Virchows Arch 467:571\u2013582","journal-title":"Virchows Arch"},{"key":"3813_CR19","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","volume":"106","author":"K Fu","year":"2005","unstructured":"Fu K, Weisenburger DD, Greiner TC et al (2005) Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 106:4315\u20134321","journal-title":"Blood"},{"key":"3813_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","volume":"123","author":"DW Scott","year":"2014","unstructured":"Scott DW, Wright GW, Williams PM et al (2014) Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood 123:1214\u20131217","journal-title":"Blood"},{"key":"3813_CR21","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki S, Arndt D, Marcu A et al (2016) Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res 44:W147\u2013W153","journal-title":"Nucleic Acids Res"},{"key":"3813_CR22","doi-asserted-by":"publisher","first-page":"101513","DOI":"10.1016\/j.beha.2023.101513","volume":"36","author":"M Grau","year":"2023","unstructured":"Grau M, L\u00f3pez C, Mart\u00edn-Subero JI et al (2023) Cytogenomics of B-cell non-Hodgkin lymphomas: The \u201cold\u201d meets the \u201cnew.\u201d. Best Pract Res Clin Haematol 36:101513","journal-title":"Best Pract Res Clin Haematol"},{"key":"3813_CR23","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1182\/bloodadvances.2019001350","volume":"4","author":"HA Hill","year":"2020","unstructured":"Hill HA, Qi X, Jain P et al (2020) Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. Blood Adv 4:2927\u20132938","journal-title":"Blood Adv"},{"key":"3813_CR24","first-page":"291","volume-title":"WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised","author":"RD Gascoyne","year":"2017","unstructured":"Gascoyne RD, Campo E, Jaffe ES et al (2017) Diffuse large B-cell lymphoma, NOS. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised, 4th edn. IARC, Lyon, pp 291\u2013297","edition":"4"},{"key":"3813_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD et al (2020) A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell 37:551\u2013568","journal-title":"Cancer Cell"},{"key":"3813_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12185-015-1812-2","volume":"102","author":"K Miyazaki","year":"2015","unstructured":"Miyazaki K, Yamaguchi M, Imai H et al (2015) Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression. Int J Hematol 102:188\u2013194","journal-title":"Int J Hematol"},{"key":"3813_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/10428194.2010.540361","volume":"52","author":"T Vela-Ch\u00e1vez","year":"2011","unstructured":"Vela-Ch\u00e1vez T, Adam P, Kremer M et al (2011) Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus. Leuk Lymphoma 52:458\u2013466","journal-title":"Leuk Lymphoma"},{"key":"3813_CR28","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1182\/bloodadvances.2019001396","volume":"4","author":"P Jain","year":"2020","unstructured":"Jain P, Zhang S, Kanagal-Shamanna R et al (2020) Genomic profiles and clinical outcomes of de novo blastoid\/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv 4:1038\u20131050","journal-title":"Blood Adv"},{"key":"3813_CR29","doi-asserted-by":"publisher","first-page":"100405","DOI":"10.1016\/j.modpat.2023.100405","volume":"37","author":"S Li","year":"2024","unstructured":"Li S, Tang G, Jain P et al (2024) Cyclin D1-negative blastoid\/pleomorphic mantle cell lymphoma or large B-cell lymphoma? Mod Pathol 37:100405","journal-title":"Mod Pathol"},{"key":"3813_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","volume":"130","author":"P Balsas","year":"2017","unstructured":"Balsas P, Palomero J, Eguileor \u00c1 et al (2017) SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. Blood 130:501\u2013513","journal-title":"Blood"},{"key":"3813_CR31","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C et al (2012) Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res 72:5307\u20135316","journal-title":"Cancer Res"},{"key":"3813_CR32","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/leu.2012.72","volume":"26","author":"C Royo","year":"2012","unstructured":"Royo C, Navarro A, Clot G et al (2012) Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia 26:1895\u20131898","journal-title":"Leukemia"},{"key":"3813_CR33","first-page":"226","volume-title":"WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised","author":"K Foucar","year":"2017","unstructured":"Foucar K, Falini B, Stein H (2017) Hairy cell leukemia. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised, 4th edn. IARC, Lyon, pp 226\u2013228","edition":"4"},{"key":"3813_CR34","first-page":"241","volume-title":"WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised","author":"RW McKenna","year":"2017","unstructured":"McKenna RW, Kyle RA, Kuehl WM et al (2017) Plasma cell neoplasms. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of the Tumours of Haematopoietic and Lymphoid Tissues, revised, 4th edn. IARC, Lyon, pp 241\u2013258","edition":"4"},{"key":"3813_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/PAS.0b013e31821ddaec","volume":"35","author":"D Chen","year":"2011","unstructured":"Chen D, Ketterling RP, Hanson CA et al (2011) A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited. Am J Surg Pathol 35:1080\u20131084","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03813-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T06:05:30Z","timestamp":1723788330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03813-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03813-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"10 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Boards of Chang Gung Medical Foundation (201902130B0, 202000483B0, 202201498B0, and 202202021B0) and Chi-Mei Medical Center (10604-003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}